ES469005A1 - Un procedimiento para la preparacion de nuevos derivados de somatostatina - Google Patents

Un procedimiento para la preparacion de nuevos derivados de somatostatina

Info

Publication number
ES469005A1
ES469005A1 ES469005A ES469005A ES469005A1 ES 469005 A1 ES469005 A1 ES 469005A1 ES 469005 A ES469005 A ES 469005A ES 469005 A ES469005 A ES 469005A ES 469005 A1 ES469005 A1 ES 469005A1
Authority
ES
Spain
Prior art keywords
phe
cys
lys
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES469005A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES469005A1 publication Critical patent/ES469005A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/28—Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

Un procedimiento para la preparación de nuevos derivados de somatostatina de fórmula I, H-D-Val-Gly-L-Cys-L-Lys-Asn''1''phe- L-Trp-L-Lys-L-Thr-Phe-L-Thr-L-Ser-L-Cys-Om, y las sales de adición de ácido, no tóxicas, farmacéuticamente aceptables del mismo, que se caracteriza por hacer reaccionar el tetradecapético de cadena lineal, correspondiente, de fórmula III, H-D-Val-Gly-L-Cys-L-Lys-L-Asn-L-Phe-L-Phe-L-Trp-L-Lys-L- Phe-L-Thr-L-Ser-L- Cys-OH, con un agente de oxidación.
ES469005A 1977-04-21 1978-04-20 Un procedimiento para la preparacion de nuevos derivados de somatostatina Expired ES469005A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/789,472 US4100117A (en) 1977-04-21 1977-04-21 Somatostatin analogs and intermediates thereto

Publications (1)

Publication Number Publication Date
ES469005A1 true ES469005A1 (es) 1979-09-01

Family

ID=25147748

Family Applications (2)

Application Number Title Priority Date Filing Date
ES469005A Expired ES469005A1 (es) 1977-04-21 1978-04-20 Un procedimiento para la preparacion de nuevos derivados de somatostatina
ES476901A Expired ES476901A1 (es) 1977-04-21 1979-01-16 Un procedimiento para la preparacion de nuevos derivados de somatostatina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES476901A Expired ES476901A1 (es) 1977-04-21 1979-01-16 Un procedimiento para la preparacion de nuevos derivados de somatostatina.

Country Status (31)

Country Link
US (1) US4100117A (es)
JP (1) JPS53132588A (es)
AR (1) AR221699A1 (es)
AT (1) AT361142B (es)
AU (1) AU519275B2 (es)
BE (1) BE866117A (es)
BG (1) BG28703A3 (es)
CA (2) CA1102315A (es)
CH (1) CH634039A5 (es)
CS (1) CS202096B2 (es)
DD (1) DD135900A5 (es)
DE (1) DE2816854A1 (es)
DK (1) DK174278A (es)
ES (2) ES469005A1 (es)
FI (1) FI64576C (es)
FR (1) FR2387941A1 (es)
GB (1) GB1596328A (es)
GR (1) GR68945B (es)
HU (1) HU177435B (es)
IE (1) IE46868B1 (es)
IL (1) IL54533A (es)
IT (1) IT1094462B (es)
NL (1) NL7804218A (es)
NZ (1) NZ187009A (es)
PL (2) PL115827B1 (es)
PT (1) PT67913B (es)
RO (2) RO81079A (es)
SE (1) SE7804397L (es)
SU (2) SU730295A3 (es)
YU (1) YU91578A (es)
ZA (1) ZA782247B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202802A (en) * 1978-10-02 1980-05-13 Eli Lilly And Company Peptides related to somatostatin
US4199501A (en) * 1978-11-20 1980-04-22 Eli Lilly And Company Peptides related to somatostatin
US4199500A (en) * 1978-11-20 1980-04-22 Eli Lilly And Company Peptides related to somatostatin
US4428942A (en) 1982-05-17 1984-01-31 The Salk Institute For Biological Studies Analogs of somatostatin
GB8423431D0 (en) * 1984-09-17 1984-10-24 Sandoz Ltd Organic compounds
SE8702550D0 (sv) * 1987-06-18 1987-06-18 Anders Grubb Cysteinproteashemmare
NZ240214A (en) 1990-10-16 1993-02-25 Takeda Chemical Industries Ltd Polymer compositions comprising a polylactic acid and a copolymer of glycolic acid and a hydroxycarboxylic acid; use as carrier for prolonged release pharmaceutical compositions of water soluble drugs
ATE161716T1 (de) 1992-08-07 1998-01-15 Takeda Chemical Industries Ltd Herstellung von mikrokapseln, die wasserlösliche arzneimittel enthalten
ATE178789T1 (de) * 1994-02-21 1999-04-15 Takeda Chemical Industries Ltd Polyester matrix für eine pharmazeutische zusammensetzung mit verzögerter freigabe
US6117455A (en) 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
CN1095681C (zh) * 1996-06-20 2002-12-11 久光制药株式会社 一种用于离子电渗疗法的装置结构
US6309633B1 (en) 1999-06-19 2001-10-30 Nobex Corporation Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
US7169889B1 (en) 1999-06-19 2007-01-30 Biocon Limited Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
WO2002043709A1 (fr) 2000-12-01 2002-06-06 Takeda Chemical Industries, Ltd. Procede de production d'une preparation contenant une substance bioactive
US6867183B2 (en) * 2001-02-15 2005-03-15 Nobex Corporation Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7060675B2 (en) * 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US6835802B2 (en) * 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828305B2 (en) * 2001-06-04 2004-12-07 Nobex Corporation Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7713932B2 (en) * 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
US6713452B2 (en) 2001-06-04 2004-03-30 Nobex Corporation Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6858580B2 (en) * 2001-06-04 2005-02-22 Nobex Corporation Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6913903B2 (en) * 2001-09-07 2005-07-05 Nobex Corporation Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7166571B2 (en) * 2001-09-07 2007-01-23 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7312192B2 (en) * 2001-09-07 2007-12-25 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7196059B2 (en) 2001-09-07 2007-03-27 Biocon Limited Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
WO2003105768A2 (en) * 2002-06-13 2003-12-24 Nobex Corporation Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
CN101027318B (zh) * 2004-07-19 2016-05-25 比奥孔有限公司 胰岛素-低聚物共轭物，制剂及其用途
US9241908B2 (en) 2007-10-16 2016-01-26 Biocon Limited Orally administrable solid pharmaceutical composition and a process thereof
US20150157619A1 (en) 2012-07-10 2015-06-11 Takeda Pharmaceutical Company Limited Pharmaceutical preparation for injection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2608336A1 (de) * 1975-03-11 1976-09-30 Sandoz Ag Neue organische verbindungen, ihre herstellung und verwendung
US4372884A (en) * 1975-08-06 1983-02-08 The Salk Institute For Biological Studies Pharmaceutically active peptides

Also Published As

Publication number Publication date
AR221699A1 (es) 1981-03-13
AT361142B (de) 1981-02-25
YU91578A (en) 1983-01-21
BG28703A3 (bg) 1980-06-16
GR68945B (es) 1982-03-29
SE7804397L (sv) 1978-10-22
AU519275B2 (en) 1981-11-19
CA1113928A (en) 1981-12-08
PL114533B1 (en) 1981-02-28
IT1094462B (it) 1985-08-02
FI64576C (fi) 1983-12-12
DD135900A5 (de) 1979-06-06
RO76054A (ro) 1981-08-17
PT67913B (en) 1979-11-14
SU904519A3 (ru) 1982-02-07
IE46868B1 (en) 1983-10-19
IT7822552A0 (it) 1978-04-20
JPS53132588A (en) 1978-11-18
HU177435B (en) 1981-10-28
IL54533A (en) 1982-11-30
SU730295A3 (ru) 1980-04-25
PL206280A1 (es) 1980-01-02
US4100117A (en) 1978-07-11
ZA782247B (en) 1979-12-27
FR2387941A1 (fr) 1978-11-17
DK174278A (da) 1978-10-22
PL115827B1 (en) 1981-05-30
RO81079A (ro) 1983-06-01
PT67913A (en) 1978-05-01
GB1596328A (en) 1981-08-26
NZ187009A (en) 1981-04-24
NL7804218A (nl) 1978-10-24
CA1102315A (en) 1981-06-02
BE866117A (fr) 1978-10-19
ATA282878A (de) 1980-07-15
CS202096B2 (en) 1980-12-31
DE2816854A1 (de) 1978-11-02
IL54533A0 (en) 1978-07-31
FR2387941B1 (es) 1983-06-10
RO81079B (ro) 1983-05-30
CH634039A5 (de) 1983-01-14
ES476901A1 (es) 1979-10-16
IE780765L (en) 1978-10-21
AU3525378A (en) 1979-10-25
FI64576B (fi) 1983-08-31
FI781184A7 (fi) 1978-10-22

Similar Documents

Publication Publication Date Title
ES8500276A1 (es) Procedimiento para preparar n2-acil-9-(1,3-dihidroxi-2-propoximetil)-guaninas y sus sales famaceuticamente aceptables.
AR218326A1 (es) Un procedimiento para la fabricacion de derivados de 1,1,2-trifenilalqueno
SE7607597L (sv) Spermicid vaginalkomposition omfattande 1,2-bensisotiazolderivat
ES8407049A1 (es) Un procedimiento para la preparacion de compuestos biciclicos.
BG34336A3 (bg) Метод за получаване на производни на фталазин -4- ил-оцетна киселина
ES2028857T3 (es) Procedimiento para la preparacion de derivados de amino-tiazol y amino-oxazol.
ES8101537A1 (es) Un procedimiento para preparar nuevas fenetanolaminas
IT7826674A0 (it) Derivati dell'acido glicil-metil-fosfinico, loro preparazione e loro impiego.
ES2056153T3 (es) Expectorante que comprende un derivado hidroxialquilcisteina.
ES480149A0 (es) Un procedimiento para la preparacion de nuevos derivados ciclicos oxigenados.(como divisional de la patente numero 480.149)
AR216744A1 (es) Nuevos derivados de la fenil-3-oxadiazolina-1,3,4-ona-2,particularmente utiles como agentes activos insecticidas,acaricidas y nematocidas,procedimiento para la preparacion de dichos derivados,composiciones insecticidas,acaricidas y nematocidas que contienen a dichos nuevos derivados
IT8025159A0 (it) Preparato medicinale ad azione citostatica, nonche' derivati dell'acido isocianurico eprocedimento per la loro preparazione.
SE7411243L (es)
ES482420A1 (es) Un procedimiento para la preparacion de 4-desoxi-4-acilamino-derivados de eritromicilamina.
ES481233A0 (es) Un procedimiento para la preparacion de derivados del acido 4,5-dihidro-4-oxofuran-2-carboxilico
SE7609495L (sv) N-tetrahydrofurfuryl-noroximorfon, dess syraadditionssalter, lekemedel innehallande dessa samt forfarande for framstellning derav
AR241108A2 (es) Insecticidas piretroides, acidos ciclopropancarboxilicos y esteres intermediarios y sus precedimientos de preparacion
NO902157D0 (no) Butensyrederivater for terapeutisk anvendelse.
MA18596A1 (fr) Derives halogenes de 1-azolyl-1 fluorophenoxybutane, leur production et leur application comme fongicides
ES480265A0 (es) Un procedimiento para la preparacion de derivados del acido 7-oxo-1-aza-biciclo (3,2,0) hept-2-en-2-carboxilico
MX9203234A (es) Derivados de 5-halovinil-2-desoxiuridina y composiciones farmaceuticas que los contienen.
FR2374292A1 (fr) Derives de l'acide 2,5-dihydroxybenzoique et applications a titre de medicament
ES8504182A1 (es) Procedimiento para preparar nuevos derivados de piperidina
IT7827490A0 (it) Imidi dell'acido n-fenil-succinico sostituite, procedimento per laloro preparazione e loro impiegocome fungicidi.
ES462849A1 (es) Un procedimiento para la preparacion de nuevos derivados de 3,5-diona-4,4-dimetil-pirrolidina.